Role of aldo-keto reductases and other doxorubicin pharmacokinetic genes in doxorubicin resistance, DNA binding, and subcellular localization

Overview of attention for article published in BMC Cancer, August 2012

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (77th percentile)
Good Attention Score compared to outputs of the same age and source (79th percentile)

Mentioned by

patent: 2 patents

Citations

dimensions_citation: 78 Dimensions

Readers on

mendeley: 85 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 2 patents that reference this research output.

Antitumoral bioconjugates of hyaluronic acid or its derivatives obtained by indirect…

Application EP-2548582-B1

European Patent Office

METABOLICALLY-ACTIVATED DRUG CONJUGATES TO OVERCOME RESISTANCE IN CANCER THERAPY

Application WO-2015149001-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.